Status:
ENROLLING_BY_INVITATION
Identification of Nerves Using Fluorescein Sodium
Lead Sponsor:
Stanford University
Collaborating Sponsors:
National Institute on Deafness and Other Communication Disorders (NIDCD)
Conditions:
Pleomorphic Adenoma of the Parotid
Warthin Tumor
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to see if there is benefit in using an IV contrast (sodium fluorescein) to identify nerves during head and neck surgery.
Eligibility Criteria
Inclusion
- Male or female subjects
- 18 years or older
- Scheduled for open head and neck surgery
Exclusion
- Inability or unwillingness of a subject
- Pregnancy
- Vulnerable or disadvantaged population (pregnant women, decisionally impaired, homeless, employees, students)
- Patients with severe medical condition(s) that in the view of the investigator prohibits participation in the study
- History of adverse reaction to fluorescein including allergy.
- History of renal failure or chronic kidney disease
Key Trial Info
Start Date :
November 7 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06054178
Start Date
November 7 2024
End Date
September 1 2025
Last Update
July 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford Medical Center
Palo Alto, California, United States, 94304